AEMETIS, INCAMTX

時価総額

$7530.2万

PER

再生可能燃料と再生天然ガス事業の新興企業。Keyesの年産6,500万ガロンのエタノール設備、乳業由来RNG、インドのバイオディーゼル事業を展開。2024年にATMで990万株を発行し3,180万ドルを調達。米国カリフォルニア、インド

	2011年 12月31日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Net loss	-18,296,359	-4,282,265	-24,437,209	7	-27	-16	-32	-36	-39	-37	-47	-108	-46	-88
Share-based compensation	177,278	686,059	2	1	1	1	1	1	1	1	4	6	8	8
Depreciation	-	-	-	5	5	5	5	5	4	5	5	6	7	8
Debt related fees and amortization expense	-	-	-	6	7	6	5	8	5	3	4	7	7	6
Intangibles and other amortization expense	-	-	253,600	0	0	0	0	0	0	0	0	0	0	0
Accretion and other expenses of Series A preferred units	-	-	-	-	-	-	-	0	2	5	8	10	25	13
Loss on asset disposals	-	-	-	-0	-	-0	-	-0	-	-	-	-	-	-4
Warrants issued for working capital agreement	-	-	-	-	-	-	-	-	-	-	-	-	-0	-
Gain on debt extinguishment	-	-9,068,868	-	-1	-0	2	-	-	-	-	-1	-49	-	0
Deferred tax (benefit) expense	-	-	-	-	-	-	-	-	1	-1	-	1	-1	-
Accounts receivable	-	-	-	-	-	-	-	-	-	-	-	-0	7	-7
Inventories	-3,724,088	-740,242	210,837	0	0	-2	2	1	0	-2	-2	-0	14	8
Prepaid expenses	-172,840	148,166	13,535	0	-1	0	-0	-2	-0	-0	-5	-2	-2	-2
Tax credit sale receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	12
Other assets	-	-	-	-	-	-	-	-	-	-	-	4	2	3
Accounts payable	-	799,620	-	-1	2	-2	3	2	1	1	-8,000	2	14	-1
Accrued interest expense and fees, net of interest paid	-	4	-	3	10	6	11	12	18	22	14	16	24	28
Other liabilities	-	-	-	-3	1	0	1	0	7	0	1	-10	-2	3
Net cash provided by (used in) operating activities	-1,246,899	-16,931,727	-1,683,125	21	-1	0	-9	-6	-2	2	-21	-23	14	-33
Capital expenditures	3	1	1	2	0	1	1	4	9	19	27	39	33	20
Grant proceeds received for capital expenditures	-	-	-	-	-	-	-	-	-	-	-	8	9	6
Net cash used in investing activities	-967,957	-16,464,229	223,997	-2	-0	-1	-1	-4	-9	-17	-23	-31	-24	-14
Proceeds from borrowings	-	-	-	-	-	-	15	20	55	13	-	69	75	19
Repayments of borrowings	-	-	-	-	-	-	-	-	-	-	-	26	56	5
Lender debt renewal and waiver fee payments	-	-	-	-	-	-	-	-	-	-	-	-	2	1
Payments on Series A preferred financing	-	-	-	-	-	-	-	-	-	-	0	-	30	-
Payments on finance leases	-	-	-	-	-	-	-	-	-	1	1	0	0	0
Proceeds from sale of common stock	-	-	-	-	-	-	-	-	-	5	104	12	22	32
Proceeds from the exercise of stock options	-	-	-	-	-	-	-	-	-	0	1	0	0	0
Net cash provided by financing activities	2	33	6	-23	1	2	8	10	10	15	51	54	9	45
Effect of exchange rate changes on cash and cash equivalents and restricted cash	-	-	-	-	-	-	-	-	-	-	-	-0	0	0
Net change in cash and cash equivalents and restricted cash for period	-	-	-	-	-	-	-	-	-	-	7	-1	-1	-2
Cash paid for interest	-	-	5	7	0	5	3	6	2	1	6	20	10	9
Income taxes paid	3,200	4,000	-5,765	0	0	0	0	0	0	0	0	0	0	2
Settlement of AP via issuance of RSAs	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Subordinated debt extension fees added to debt	-	-	-	-	-	-	-	-	-	-	1	1	1	1
Fair value of warrants issued to subordinated debt holders	-	-	-	-	-	-	0	0	-	-	2	2	1	1
Fair value of warrants issued to lender for debt issuance costs	-	-	-	-	-	-	-	-	-	-	-	3	0	-
Lender debt extension, waiver, and other fees added to debt	-	-	-	-	-	-	-	-	-	-	-	1	-	1
Cumulative capital expenditures in accounts payable	-	-	-	-	-	-	-	-	-	-	-	15	8	11